193965-35-4

Usage

Uses

Used in Pharmaceutical Industry:
7-Methoxybenzo[B]Thiophene-2-Boronic Acid is used as a key intermediate for the synthesis of various biologically active molecules, contributing to the development of new drugs and therapeutic agents. Its potential biological activities and unique structure make it a promising candidate for the creation of complex organic compounds with medicinal properties.
Used in Agrochemical Industry:
7-Methoxybenzo[B]Thiophene-2-Boronic Acid is utilized as a building block in the synthesis of agrochemicals, such as pesticides and herbicides. Its reactivity and structural features enable the development of novel compounds with improved efficacy and selectivity in agricultural applications.

Upstream product

• 51830-50-3 1,1-diethoxy-2-(4-methylphenylthio)ethane 
• 88791-08-6 7-methoxybenzothiophene 
• 5419-55-6 Triisopropyl borate 

Relevant academic research and scientific papers

Compound with AMPK agonistic activity and preparation and application of prodrug thereof

The invention relates to a compound with AMPK agonistic activity and a prodrug thereof, and as well as a preparation method and medical application of a prodrug thereof. The compound has the structure shown in the formula (I), and the prodrug of the compound has the structure shown in the formula (II), wherein each group and the substituent are as defined in the specification. The invention discloses a preparation method of the compound and application of the compound in prevention and treatment AMPK related diseases, and the AMPK related diseases include, but are not limited to, energy metabolism abnormality related diseases. Neurodegenerative diseases and inflammation-related diseases and the like.

FGFR INHIBITOR AND MEDICAL APPLICATION THEREOF

Provided is a FGFR inhibitor, designating a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. Also provided is the application of a drug for treating solid tumors, such as FGFR related diseases.

Antithrombotic diamines

This application relates to the use as thrombin inhibitors, coagulation inhibitors and thromboembolic disorder agents of diamines of formula I as defined herein. It also provides novel compounds of formula I, processes and intermediates for their preparation, and pharmaceutical formulations comprising the novel compounds of formula I.